Citi resumed coverage of Stryker (SYK) with a Buy rating and $450 price target following the close of the Inari acquisition tryker has built a ...

Powered by rapid AI advancements, enhanced automation processes, and growing demand for commercial adoption, modern robotics ...

Stryker Corporation’s SYK shares closed the trading session at $385.18 on Friday, 5.2% below its 52-week high of $406.19 ...

Buying $100 In SYK: If an investor had bought $100 of SYK stock 15 years ago, it would be worth $720.87 today based on a price of $382.78 for SYK at the time of writing.

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...

“The acquisition of Inari Medical marks a significant milestone in expanding our interventional endovascular portfolio,” said Kevin Lobo, Chair and Chief Executive Officer, Stryker. “We look forward ...

Below is Validea's guru fundamental report for STRYKER CORP (SYK). Of the 22 guru strategies we follow, SYK rates highest using our P/B Growth Investor model based on the published strategy of ...

Stryker (SYK) came out with quarterly earnings of $4.01 per share, beating the Zacks Consensus Estimate of $3.87 per share. This compares to earnings of $3.46 per share a year ago. These figures ...

Among the largest underlying components of XLV, in trading today Stryker Corp (Symbol: SYK) is off about 0.2%, Danaher Corp (Symbol: DHR) is up about 1.9%, and Vertex Pharmaceuticals, Inc. (Symbol ...